NORTRIPTYLINE HYDROCHLORIDE

Post-LOE

nortriptyline hydrochloride

ANI Pharmaceuticals

ANDAORALCAPSULE

Approved

Jul 1993

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

NORTRIPTYLINE HYDROCHLORIDE (nortriptyline hydrochloride) by ANI Pharmaceuticals is clinical pharmacology the mechanism of mood elevation by tricyclic antidepressants is at present unknown. Approved for depression. First approved in 1993.

Drug data last refreshed 20h ago

Mechanism of Action

CLINICAL PHARMACOLOGY The mechanism of mood elevation by tricyclic antidepressants is at present unknown. Nortriptyline hydrochloride is not a monoamine oxidase inhibitor. It inhibits the activity of such diverse agents as histamine, 5-hydroxytryptamine, and acetylcholine. It increases the pressor…

Indications (1)

depression

Company

Worked on NORTRIPTYLINE HYDROCHLORIDE at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.